First Affiliated Hospital of University of Science and Technology China (USTC) R eports Findings in Artificial Intelligence (Prediction of epidermal growth facto r receptor mutation subtypes in non-small cell lung cancer from hematoxylin and ...)
First Affiliated Hospital of University of Science and Technology China (USTC) R eports Findings in Artificial Intelligence (Prediction of epidermal growth facto r receptor mutation subtypes in non-small cell lung cancer from hematoxylin and ...)
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Artificial Intelligenc e is the subject of a report. According to news reporting originating in Anhui, People’s Republic of China, by NewsRx journalists, research stated, “Accurate as sessment of epidermal growth factor receptor (EGFR) mutation status and subtype are critical for the treatment of non-small cell lung cancer (NSCLC) patients. C onventional molecular testing methods for detecting EGFR mutations have limitati ons.”
Key words
Anhui/People's Republic of China/Asia/Artificial Intelligence/Cancer/Emerging Technologies/Epidermal Growth Factor Receptor/Epidermal Growth Factors/Gastrointestinal Hormone Receptors/Gastroi ntestinal Hormones/Genetics/Growth Factor Receptors/Health and Medicine/Hosp itals/Intercellular Signaling Peptides and Proteins/Lung Cancer/Lung Diseases and Conditions/Lung Neoplasms/Machine Learning/Membrane Proteins/Non-Small Cell Lung Cancer/Oncology/Peptide Receptors/Phosphotransferases/Protein Kina ses/Receptor Protein-Tyrosine Kinases
NETL
NSTL